These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3519213)

  • 1. Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin.
    Bode W; Papamokos E; Musil D; Seemueller U; Fritz H
    EMBO J; 1986 Apr; 5(4):813-8. PubMed ID: 3519213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
    Bode W; Papamokos E; Musil D
    Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.
    McPhalen CA; Schnebli HP; James MN
    FEBS Lett; 1985 Aug; 188(1):55-8. PubMed ID: 3926539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
    Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
    J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
    Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
    J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
    Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
    FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to human leukocyte elastase, bovine alpha-chymotrypsin and subtilisin Carlsberg: thermodynamic study.
    Ascenzi P; Amiconi G; Menegatti E; Guarneri M; Bolognesi M; Schnebli HP
    J Enzyme Inhib; 1988; 2(3):167-72. PubMed ID: 3071573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C.
    Dauter Z; Betzel C; Genov N; Pipon N; Wilson KS
    Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():707-30. PubMed ID: 1793542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.
    Heinz DW; Hyberts SG; Peng JW; Priestle JP; Wagner G; Grütter MG
    Biochemistry; 1992 Sep; 31(37):8755-66. PubMed ID: 1390662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor.
    Hipler K; Priestle JP; Rahuel J; Grütter MG
    Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P; Teplyakov AV; Hol WG
    Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution.
    Frigerio F; Coda A; Pugliese L; Lionetti C; Menegatti E; Amiconi G; Schnebli HP; Ascenzi P; Bolognesi M
    J Mol Biol; 1992 May; 225(1):107-23. PubMed ID: 1583684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the role of the electrostatic interactions involving Gly70 in eglin C by total chemical protein synthesis.
    Lu WY; Starovasnik MA; Dwyer JJ; Kossiakoff AA; Kent SB; Lu W
    Biochemistry; 2000 Apr; 39(13):3575-84. PubMed ID: 10736156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing intermolecular backbone H-bonding in serine proteinase-protein inhibitor complexes.
    Lu W; Randal M; Kossiakoff A; Kent SB
    Chem Biol; 1999 Jul; 6(7):419-27. PubMed ID: 10381402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of protease-inhibitor interactions by randomizing adventitious contacts.
    Komiyama T; VanderLugt B; Fugère M; Day R; Kaufman RJ; Fuller RS
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8205-10. PubMed ID: 12832612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray crystal structure of the bovine alpha-chymotrypsin/eglin c complex at 2.6 A resolution.
    Bolognesi M; Pugliese L; Gatti G; Frigerio F; Coda A; Antolini L; Schnebli HP; Menegatti E; Amiconi G; Ascenzi P
    J Mol Recognit; 1990 Aug; 3(4):163-8. PubMed ID: 2278733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.